Detecting human papillomavirus in ocular surface diseases

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 13, 2013, Pages 8069-8078

  Woods, Mark ^a   Chow, Sharron ^a   Heng, Benjamin ^a   Glenn, Wendy ^a   Whitaker, Noel ^a   Waring, Dale ^b   Iwasenko, Jenna ^b   Rawlinson, William ^a,b   Coroneo, Minas T ^b   Wakefield, Denis ^a   Di Girolamo, Nick ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Conjunctiva; Epithelium; Neoplasia; Ocular surface; Pterygia; Virus

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN E6; PROTEIN P16; VIRUS DNA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DNA SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OCULAR SURFACE DISEASE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PTERYGIUM; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; WART VIRUS;

CONJUNCTIVA; EPITHELIUM; NEOPLASIA; OCULAR SURFACE; PTERYGIA; VIRUS;

AGED; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; CONJUNCTIVA; CONJUNCTIVAL NEOPLASMS; DNA PRIMERS; DNA, VIRAL; DNA-BINDING PROTEINS; EPITHELIAL CELLS; EYE INFECTIONS, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PTERYGIUM; REPRESSOR PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 84890030160     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13140     Document Type: Article

References (69)

1. Coroneo MT. Ultraviolet radiation and the anterior eye. Eye Contact Lens. 2011;37:214-224.
2. Booth F. Heredity in one hundred patients admitted for excision of pterygia. Aust N Z J Ophthalmol. 1985;13:59-61.
3. Rodrigues FW, Arruda JT, Silva RE, et al. TP53 gene expression, codon 72 polymorphism and human papillomavirus DNA associated with pterygium. Genet Mol Res. 2008;7:1251-1258.
4. Luthra R, Nemesure BB, Wu SY, et al. Frequency and risk factors for pterygium in the Barbados Eye Study. Arch Ophthalmol. 2001;119:1827-1832.
5. Norm MS. Prevalence of pinguecula in Greenland and in Copenhagen and its relationship to pterygium and spheroid degeneration. Acta Ophthalmol. 1979;57:96-105.
6. Hirst LW, Axelsen RA, Schwab I. Pterygium and associated ocular surface squamous neoplasia. Arch Ophthalmol. 2009; 127:31-32.
7. Chui J, Coroneo MT, Tat LT, et al. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol. 2011;178:817-827.
8. Di Girolamo N, McCluskey P, Lloyd A, et al. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:671-679.
9. Di Girolamo N, Kumar RK, Coroneo MT et al. UVB-mediated induction of interleukin-6 and -8 in pterygia and cultured human pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2002;43:3430-3437.
10. Di Girolamo N, Coroneo MT, Wakefield D. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPKdependent pathway. Invest Ophthalmol Vis Sci. 2003;44: 4705-4714.
11. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429-450.
12. Di Girolamo N. Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia. Eye (Lond). 2012;26:202-211.
13. McKelvie PA, Daniell M, McNab A, et al. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol. 2002;86:168-173.
14. Ng J, Coroneo MT, Wakefield D, et al. Ultraviolet radiation and the role of matrix metalloproteinases in the pathogenesis of ocular surface squamous neoplasia. Invest Ophthalmol Vis Sci. 2008;49:5295-5306.
15. Alves LF, Fernandes BF, Burnier JV, et al. Expression of SIRT1 in ocular surface squamous neoplasia. Cornea. 2012;31:817-819.
16. Di Girolamo N, Atik A, McCluskey PJ, et al. Matrix metalloproteinases and their inhibitors in squamous cell carcinoma of the conjunctiva. Ocul Surf. 2013;11:193-205.
17. Lee GA, Williams G, Hirst LW, et al. Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology. 1994;101:360-364.
18. Chisi SK, Kollmann MK, Karimurio J. Conjunctival squamous cell carcinoma in patients with human immunodeficiency virus infection seen at two hospitals in Kenya. East Afr Med J. 2006;83:267-270.
19. Carreira H, Coutinho F, Carrilho C, Lunet N. HIV and HPV and ocular surface squamous neoplasia: systematic review and meta-analysis. Br J Ophthalmol. 2013;109:1981-1988.
20. McDonnell JM, McDonnell PJ, Sun YY. Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci. 1992;33:184-189.
21. Piras F, Moore PS, Ugalde J, et al. Detection of human papillomavirus DNA in pterygia from different geographical regions. Br J Ophthalmol. 2003;87:864-866.
22. Piecyk-Sidor M, Polz-Dacewicz M, Zagorski Z, et al. Occurrence of human papillomavirus in pterygia. Acta Ophthalmol. 2009;87:890-895.
23. Ateenyi-Agaba C, Weiderpass E, Smet A, et al. Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Br J Cancer. 2004;90: 1777-1779.
24. Schellini SA, Hoyama E, Shiratori CA, et al. Lack of papillomavirus (HPV) in pterygia of a Brazilian sample. Arq Bras Oftalmol. 2006;69:519-521.
25. Manderwad GP, Kannabiran C, Honavar SG, et al. Lack of association of high-risk human papillomavirus in ocular surface squamous neoplasia in India. Arch Pathol Lab Med. 2009;133:1246-1250.
26. Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology. 2002;109:542-547.
27. Kuo KT, Chang HC, Hsiao CH, et al. Increased Ki-67 proliferative index and absence of P16INK4 in CIN-HPV related pathogenic pathways different from cervical squamous intraepithelial lesion. Br J Ophthalmol. 2006;90:894-899.
28. Eng HL, Lin TM, Chen SY, et al. Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva by polymerase chain reaction. Am J Clin Pathol. 2002;117:429-436.
29. Guthoff R, Marx A, Stroebel P. No evidence for a pathogenic role of human papillomavirus infection in ocular surface squamous neoplasia in Germany. Curr Eye Res. 2009;34:666-671.
30. Dushku N, Hatcher SL, Albert DM, et al. p53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch Ophthalmol. 1999;117: 1593-1599.
31. Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117:S5-S10.
32. Munoz N, Castellsague X, de Gonzalez AB, et al. HPV in the etiology of human cancer. Vaccine. 2006;24:1-10.
33. Parkin DM, Bray F. The burden of HPV-related cancers. Vaccine. 2006;24:11-25.
34. Heng B, Glenn WK, Ye Y, et al. Human papilloma virus is associated with breast cancer. Br J Cancer. 2009;101:1345-1350.
35. Purdie KJ, Pennington J, Proby CM, et al. The promoter of a novel human papillomavirus (HPV77) associated with skin cancer displays UV responsiveness, which is mediated through a consensus p53 binding sequence. EMBO J. 1999;18:5359-5369.
36. Anand B, Ramesh C, Appaji L, et al. Prevalence of high-risk human papillomavirus genotypes in retinoblastoma. Br J Ophthalmol. 2011;95:1014-1018.
37. Iuorno J, Truskinovsky A, Chung G, et al. Conjunctival condylomata acuminata. Cornea. 2008;27:621-624.
38. Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol. 2004;4:46-54.
39. Doorbar J. The papillomavirus life cycle. J Clin Virol. 2005;32: S7-S15.
40. Yoon CS, Kim KD, Park SN, et al. alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun. 2001;283:668-673.
41. Culp TD, Budgeon LR, Marinkovich MP, et al. Keratinocytesecreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol. 2006;80:8940-8950.
42. Hayashi R, Yamato M, Saito T, et al. Enrichment of corneal epithelial stem/progenitor cells using cell surface markers, integrin alpha6 and CD71. Biochem Biophys Res Commun. 2008;367:256-263.
43. Michael S, Lambert PF, Strati K. The HPV16 oncogenes cause aberrant stem cell mobilization. Virology. 2013;443:218-225.
44. Barnard P, Payne E, McMillan NA. The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha. Virology. 2000;277:411-419.
45. Ordonez, P, Chow S, Wakefield D, et al. Human limbal epithelial progenitor cells express avb5 and the interferoninducible chemokine CXCL10/IP-10. Stem Cell Res. 2013;11: 888-901.
46. Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991;265:472-477.
47. Fujinaga Y, Shimada M, Okazawa K, et al. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol. 1991;72: 1039-1044.
48. McIver CJ, Jacques CFH, Chow SSW, et al. Development of a multiplex PCRs for detection of common viral pathogens and agents of congenital infections. J Clin Microbiol. 2005;43: 5102-5110.
49. Legrand B, Mazancourt P, Durigon M, et al. DNA genotyping of unbuffered formalin fixed paraffin embedded tissues. Forensic Sci Int. 2002;125:205-211.
50. Krawczyk E, Suprynowicz FA, Liu X, et al. Koilocytosis: a cooperative interaction between the human papillomavirus E5 and E6 oncoprotein. Am J Pathol. 2008;173:682-688.
51. Simbiri KO, Murakami M, Feldman M, et al. Multiple oncogenic viruses identified in ocular surface squamous neoplasia in HIV- 1 patients. Infect Agents Cancer. 2010;5:6.
52. Detorakis ET, Sourvinos G, Spandidos DA. Detection of herpes simplex virus and human papilloma virus in ophthalmic pterygium. Cornea. 2001;20:164-167.
53. Chalkia AK, Spandidos DA, Detorakis ET. Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review). Int J Mol Med. 2013;32:539-543.
54. Sjo NC, von Buchwald C, Prause JU, Norrild B, Vinding T, Heegaard S. Human papillomavirus and pterygium. Is the virus a risk factor? Br J Ophthalmol. 2007;91:1016-1018.
55. Takamura Y, Kubo E, Tsuzuki S, Akagi Y. Detection of human papillomavirus in pterygium and conjunctival papilloma by hybrid capture II and PCR assays. Eye. 2008;22:1442-1445.
56. Toth J, Karcioglu ZA, Moshfeghi AA, et al. The relationship between human papillomavirus and p53 gene in conjunctival squamous cell carcinoma. Cornea. 2000;19:159-162.
57. Gallagher MJ, Giannoudis A, Herrington CS, et al. Human papillomavirus in pterygium. Br J Ophthalmol. 2001;85:782-784.
58. Tabrizi SN, McCurrach FE, Drewe RH, et al. Human papillomavirus in corneal and conjunctival carcinoma. Aust N Z J Ophthalmol. 1997;25:211-215.
59. Tsai YY, Chang CC, Chiang CC, et al. HPV infection and p53 inactivation in pterygium. Mol Vis. 2009;15:1092-1097.
60. zur Hausen H, de Villiers EM, Gissmann L. Papillomavirus infections and human genital cancer. Gynecol Oncol. 1981;12: S124-S128.
61. Payne D, Tyring SK, Doherty MG, et al. Detection of human papillomavirus type 16 in plasma cells. Gynecol Oncol. 1993; 48:406-412.
62. Sano T, Masuda N, Oyama T, et al. Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int. 2002;52:375-383.
63. Sen S, Sharma A, Panda A. Immunohistochemical localization of human papilloma virus in conjunctival neoplasias: a retrospective study. Ind J Ophthalmol. 2007;55:361-363.
64. Nakamura Y, Mashima Y, Kameyama K, Mukai M, Oguchi Y. Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridization, and polymerase chain reaction. Br J Ophthalmol. 1997;81:308-311.
65. Guo M, Sneige N, Silva EG, et al. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol. 2007;20:256-266.
66. Herrera-Goepfert R, Khan NA, Koriyama C, Akiba S, Perez- Sanchez VM. High-risk human papillomavirus in mammary gland carcinomas and non-neoplastic tissues of Mexican women: no evidence supporting a cause and effect relationship. Breast. 2011;20:184-189.
67. McDonnell JM, Mayr AJ, Martin WJ. DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med. 1989;320:1442-1446.
68. Hughes DS, Powell N, Fiander AN. Will vaccination against human papillomavirus prevent eye disease? A review of the evidence. Br J Ophthalmol. 2008;92:460-465.
69. Shah SU, Kaliki S, Kim J, et al. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases. Arch Ophthalmol. 2012;130:159-164.